Jónsson H, Schubert M, Seguin-Orlando A, Ginolhac A, Petersen L, Fumagalli M, Albrechtsen A, Petersen B, Korneliussen TS, Vilstrup JT, Lear T, Myka JL, Lundquist J, Miller DC, Alfarhan AH, Alquraishi SA, Al-Rasheid KA, Stagegaard J, Strauss G, Bertelsen MF, Sicheritz-Ponten T, Antczak DF, Bailey E, Nielsen R, Willerslev E, Orlando L. Prehistoric genomes reveal the genetic foundation and cost of horse domestication. Schubert M, Jónsson H, Chang D, Der Sarkissian C, Ermini L, Ginolhac A, Albrechtsen A, Dupanloup I, Foucal A, Petersen B, Fumagalli M, Raghavan M, Seguin-Orlando A, Korneliussen TS, Velazquez AM, Stenderup J, Hoover CA, Rubin CJ, Alfarhan AH, Alquraishi SA, Al-Rasheid KA, MacHugh DE, Kalbfleisch T, MacLeod JN, Rubin EM, Sicheritz-Ponten T, Andersson L, Hofreiter M, Marques-Bonet T, Gilbert MT, Nielsen R, Excoffier L, Willerslev E, Shapiro B, Orlando L. Uncovering the genetic history of the present-day Greenlandic population. Moltke I, Fumagalli M, Korneliussen TS, Crawford JE, Bjerregaard P, Jørgensen ME, Grarup N, Gulløv HC, Linneberg A, Pedersen O, Hansen T, Nielsen R, Albrechtsen A. GC-Content evolution in bacterial genomes: the biased gene conversion hypothesis expands. Lassalle F, Périan S, Bataillon T, Nesme X, Duret L, Daubin V. The genomic and phenotypic diversity of Schizosaccharomyces pombe. Jeffares DC, Rallis C, Rieux A, Speed D, Převorovský M, Mourier T, Marsellach FX, Iqbal Z, Lau W, Cheng TM, Pracana R, Mülleder M, Lawson JL, Chessel A, BalaS, Hellenthal G, O'Fallon B, Keane T, Simpson JT, Bischof L, Tomiczek B, Bitton DA, Sideri T, Codlin S, Hellberg JE, van Trigt L, Jeffery L, Li JJ, Atkinson S, Thodberg M, Febrer M, McLay K, Drou N, Brown W, Hayles J, Carazo Salas RE, Ralser M, Maniatis N, Balding DJ, Balloux F, Durbin R, Bähler J. A novel bioassay to monitor fungicide sensitivity in Mycosphaerella fijiensis. Ngando JE, Rieux A, Nguidjo O, Pignolet L, Dubois C, Mehl A, Zapater MF, Carlier J, de Lapeyre de Bellaire L. Rates of vaccine evolution show strong effects of latency: implications for varicella zoster virus epidemiology. Weinert LA, Depledge DP, Kundu S, Gershon AA, Nichols RA, Balloux F, Welch JJ, Breuer J. Four decades of transmission of a multidrug-resistant Mycobacterium tuberculosis outbreak strain. Scientific Rep(2018).Ī BAYESIAN NONPARAMETRIC APPROACH FOR CANCER RADIOMICS: ELUCIDATING TEXTURAL PATTERN HETEROGENEITY OF SOLID LESIONS.Eldholm V, Monteserin J, Rieux A, Lopez B, Sobkowiak B, Ritacco V, Balloux F. Development of an Immune-Pathology Informed Radiomics Model for Non-Small Cell Lung Cancer. Predictive classification of correlated targets with application to detection of metastatic cancer using functional CT imaging. Statistical Methods for Establishing Personalized Treatment Rules in Oncology. Integrative Bayesian analysis of neuroimaging-genetic data with application to cocaine dependence. Bayesian Predictive Modeling for Genomic Based Personalized Treatment Selection. Tree-based Methods for Characterizing Tumor Density Heterogeneity. IEEE 15th International Symposium on Biomedical Imaging (ISBI 2018). Bayesian classifiers of solid lesions with dynamic CT: Integrating enhancement density with washout density and delay interval. A Visually Apparent and Quantifiable CT Imaging Feature Identifies Biophysical Subtypes of Pancreatic Ductal Adenocarcinoma. Development and Validation of a Predictive Radiomics Model for Clinical Outcomes in Stage I Non-small Cell Lung Cancer. Integrating genomic signatures for treatment selection with Bayesian predictive failure time models. An Efficient Nonparametric Estimate for Spatially Correlated Functional Data. Spatial Bayesian modeling of GLCM with application to malignantlesion characterization.

Bayesian personalized treatment selection strategies that integrate predictive with prognostic determinants. Estimating mean local posterior predictive benefit for biomarker-guided treatment strategies. Statistical Methods in Medical Research 29.1 (2020): 137-150. al, A functional model for classifying metastatic lesions integrating scans and biomarkers. Biomarkers can be used as targets to devise treatment strategies that exploit current understanding of the biological mechanisms of the disease. Biomarker Driven Studies Matching Patients with Therapy.

Perian biosciences